Home / News in the field of andrology / Innovation / PSMA is a new word in the diagnosis and treatment of prostate cancer

PSMA-617 - a new agent for diagnosing cancer

Scientists of the German scientific Institute revealed a correlation between the content of PSMA antigen in the superficial tissues of the prostate, as well as its amount in relation with the disease risk of prostate cancer. High antigen concentration is indicative of nascent tumor cells, which can become a great breakthrough in the diagnosis of this disease.

Professor M. Eder and his team have developed a special substance is molecular in nature, PSMA-617. Molecule searches for malicious squirrels attached to him and notes his radioactive substance of a particular type. Using a plan of substances, it becomes possible mark appearing malignant tumors. Thus, according to the inventors, it becomes possible not only the diagnosis of prostate cancer in the early stages of the disease, but the treatment thereof. The patients of special substances, such as actinium-255, etc., according to the research results, lets get some progress (within 70% of cases) in the treatment of prostate cancer.